Adderall XR Cost in New Hampshire 2026

What Does Adderall XR Actually Cost in New Hampshire Right Now?

The cash price for generic Adderall XR at New Hampshire retail pharmacies averaged around $30 per month in 2026, a steep drop from the brand-name list price of approximately $260 per month. That gap exists because multiple generic manufacturers, including Teva Pharmaceuticals, Sandoz, and Amneal, now supply mixed amphetamine salts extended-release capsules to the U.S. market. Comparing prices at specific chain and independent pharmacies in New Hampshire before filling a prescription can save patients $10 to $40 per fill, depending on the dispensing pharmacy's acquisition cost and markup.

Why Such a Large Gap Between List Price and Street Price?

Brand-name Adderall XR received FDA approval in 2001, and the reference label is maintained by Teva under NDA 021303. When a drug goes multi-source generic, pharmacy chains negotiate directly with wholesalers. The result is a cash price that can fall 80 to 90 percent below the Wholesale Acquisition Cost. Patients paying full out-of-pocket should request the generic explicitly at the pharmacy counter, because some software systems default to the brand.

How Dose Strength Affects Price in New Hampshire

Adderall XR is dispensed in 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg capsules. Prices across New Hampshire pharmacies in early 2026 suggest a modest difference of roughly $2 to $8 between the lowest and highest strengths for a 30-capsule supply. Patients prescribed two capsules per day (60 capsules monthly) should budget closer to $50 to $65 cash pay, depending on pharmacy and strength.

Does New Hampshire Medicaid Cover Adderall XR?

New Hampshire Medicaid (NH Healthy Families and Well Sense Health Plan, the state's managed care organizations) does not currently cover Adderall XR as a covered outpatient pharmacy benefit for adults or children. Families relying on Medicaid for pediatric ADHD treatment face a coverage gap that forces them to explore alternatives such as prior-authorization appeals, state pharmaceutical assistance programs, or switching to a different stimulant that does appear on the Medicaid preferred drug list.

Which Stimulants Does NH Medicaid Cover?

The New Hampshire Medicaid Preferred Drug List periodically updates, and clinicians should verify coverage at the point of prescribing. As of the most recent published list, immediate-release amphetamine formulations and some methylphenidate-based products carry preferred status. Atomoxetine (Strattera), a non-stimulant ADHD medication, is also covered and may be an option for patients for whom stimulants are contraindicated. Families should ask their prescribing clinician to check the current PDL before assuming a specific product is covered. The New Hampshire DHHS Medicaid pharmacy pages are the authoritative reference.

Filing a Prior Authorization for Adderall XR Under NH Medicaid

Even when a drug is not on the preferred list, Medicaid plans in New Hampshire allow a prescriber to submit a prior authorization request documenting medical necessity. The approval rate for stimulant PA requests varies, but a prescriber's documentation of a formal ADHD diagnosis with DSM-5 criteria, functional impairment, and a trial of a preferred agent can strengthen the submission. Approval is not guaranteed. Patients denied PA have the right to a formal appeal under 42 CFR Part 431.

Is Compounded Mixed Amphetamine Salts Legal in New Hampshire?

Yes. New Hampshire permits licensed 503A compounding pharmacies to prepare mixed amphetamine salts for individual patients, provided a valid patient-specific prescription from a licensed prescriber exists. This is distinct from 503B outsourcing facilities, which compound for hospital use. The FDA framework for 503A pharmacies requires that compounded preparations not be essentially a copy of a commercially available approved drug and that they meet patient-specific needs. Because a nationwide shortage of Adderall XR has been formally acknowledged, the commercial-copy restriction has had a narrower practical effect in recent years.

What Does Compounded Mixed Amphetamine Salts Cost in New Hampshire?

Pricing at New Hampshire 503A pharmacies varies considerably. Some compounding pharmacies charge $0 for the drug itself when it is prepared as part of a bundled telehealth or subscription model; others charge $40 to $120 per month depending on dose and quantity. Patients should confirm that the specific 503A pharmacy holds a current New Hampshire Board of Pharmacy license and that the prescribing clinician has verified the pharmacy's accreditation (PCAB accreditation through the Pharmacy Compounding Accreditation Board is a common quality marker).

Legal Caveats to Know Before Ordering Compounded Amphetamines

Mixed amphetamine salts remain a Schedule II controlled substance under the federal Controlled Substances Act, regardless of whether the preparation is compounded or commercially manufactured. A prescriber cannot call in, fax without original follow-up, or issue refillable prescriptions for Schedule II substances in New Hampshire. Every monthly supply requires a new, separate written or electronic prescription under 21 U.S.C. § 829. Patients who receive compounded mixed amphetamine salts through a telehealth provider must ensure that the prescribing clinician holds a valid DEA registration and a New Hampshire state license.

Can You Get Adderall XR Through Telehealth in New Hampshire?

Telehealth prescribing of Adderall XR is legal in New Hampshire as of 2026. The federal DEA temporary telemedicine rule, first issued during the COVID-19 public health emergency, was extended through a series of interim final rules, and prescribing of Schedule II stimulants via telemedicine remains permissible for established patients who meet DEA requirements. New prescriptions for Schedule II substances via telemedicine without a prior in-person visit are subject to evolving federal guidance, so patients starting ADHD treatment for the first time should confirm with their telehealth provider whether a virtual-only visit satisfies current DEA rules or whether a one-time in-person evaluation is required.

New Hampshire also passed telehealth parity legislation requiring commercial insurers to reimburse telehealth visits at rates comparable to in-person visits, which reduces cost barriers for patients seeking ADHD evaluation online. The American Telemedicine Association's state policy resource tracks parity status by state.

What a Telehealth ADHD Visit in New Hampshire Typically Involves

A first telehealth ADHD evaluation in New Hampshire generally runs 45 to 60 minutes. The clinician collects a developmental and psychiatric history, reviews prior records if available, may administer validated rating scales such as the Adult ADHD Self-Report Scale (ASRS) or Conners rating scales for children, and documents DSM-5 diagnostic criteria. The MTA Cooperative Group study (Arch Gen Psychiatry 1999, N=579) established that combined behavioral and pharmacological treatment produced the largest effect sizes for ADHD symptom reduction, with medication management alone outperforming behavioral treatment alone on core ADHD symptoms at 14 months. That evidence base informs why clinicians prioritize accurate diagnosis before prescribing stimulants.

Follow-up visits for refills of Schedule II medications via telehealth occur monthly in most New Hampshire practices, as no refills are permitted on a single prescription. Patients should factor in the cost of monthly follow-up visits ($0 to $75 depending on insurance and provider) when calculating total treatment cost.

Which Insurance Plans Cover Adderall XR in New Hampshire?

Most commercial insurance plans available through the New Hampshire Marketplace (healthcare.gov) and employer-sponsored plans cover generic mixed amphetamine salts extended-release capsules, though the tier placement varies. A Tier 2 generic placement typically results in a $10 to $20 copay per 30-day fill. A Tier 3 non-preferred placement can run $40 to $70. Brand-name Adderall XR, when dispensed instead of generic, may land on Tier 4 or specialty tier, generating a $90 to $200 copay even with insurance.

Checking Your Specific Plan's Formulary

New Hampshire residents can verify formulary placement at healthcare.gov's plan comparison tool by entering the drug name and dose during plan selection. Employers using self-funded ERISA plans are not required to follow state insurance mandates, so formulary decisions for those plans may differ. Calling the pharmacy benefits number on the back of an insurance card and asking specifically for the generic mixed amphetamine salts extended-release tier placement takes about four minutes and eliminates guesswork.

Prior Authorization Under Commercial Insurance in New Hampshire

Several commercial plans in New Hampshire require prior authorization for Adderall XR even when it is a covered benefit, particularly for adults. Authorization criteria typically require documentation of an ADHD diagnosis by DSM-5 criteria, functional impairment in two or more settings, and sometimes a statement that the patient has not responded adequately to a methylphenidate-based product. The prescribing clinician submits this documentation; patients rarely need to contact the insurer directly during the initial PA submission.

What Are the Cheapest Ways to Get Adderall XR in New Hampshire?

The most cost-effective options in New Hampshire, ranked by typical monthly out-of-pocket cost, are:

1. Generic mixed amphetamine salts XR with a GoodRx or similar discount coupon. Prices at Costco Pharmacy in Manchester or Concord, for example, can fall to $15 to $25 for a 30-capsule supply of 20 mg using a free savings card. GoodRx, RxSaver, and Blink Health all operate in New Hampshire.

2. Compounded mixed amphetamine salts via a licensed 503A pharmacy. Where covered by a bundled telehealth subscription, out-of-pocket cost may be $0 for the medication itself. Confirm legality and pharmacy licensure before proceeding.

3. Manufacturer patient assistance programs. Teva's patient assistance program offers free brand-name Adderall XR to qualifying patients with incomes below 400% of the federal poverty level. Applications are submitted through the prescribing clinician's office. NeedyMeds maintains a current database of these programs.

4. New Hampshire Prescription Drug Affordability Program. New Hampshire passed SB 243 (2023) establishing a Prescription Drug Affordability Board. The board's drug cost review process may result in upper payment limits that reduce out-of-pocket costs for certain high-spend drugs, though stimulants have not yet been subject to a formal cost review as of early 2026.

5. State pharmacy assistance for low-income adults not covered by Medicaid. The New Hampshire Senior Prescription Drug Discount Program is primarily for adults 65 and older but provides a template for income-based discount access.

A Practical Decision Framework for New Hampshire Patients Seeking Lower Adderall XR Costs

Use the following four questions to identify the lowest-cost path before calling the pharmacy:

Step 1. Do you have commercial insurance? If yes, check your formulary tier for generic mixed amphetamine salts XR. If the copay is <$30, fill there.

Step 2. If uninsured or if your copay exceeds $30, compare GoodRx, RxSaver, and Blink Health prices at your nearest pharmacy. Prices vary by ZIP code; the Manchester and Nashua areas generally have more competition and lower prices than rural NH counties.

Step 3. If your income is below 250% of the federal poverty level, ask your prescribing clinician about Teva's patient assistance program or NeedyMeds-listed alternatives before paying cash.

Step 4. If a commercial 503A compounding option is being considered, confirm that the prescribing clinician holds both a valid New Hampshire license and a current DEA Schedule II registration before sending any payment.

How the Adderall Shortage Affects New Hampshire Pricing and Availability

The FDA placed Adderall on the drug shortage list in October 2022, and supply constraints have persisted through 2025 into 2026 for specific manufacturers and dose strengths. Shortage conditions in New Hampshire have two effects on pricing: some retail pharmacies have limited quantities available, which can force patients to try multiple pharmacies, and some telehealth providers have positioned compounded mixed amphetamine salts as a shortage-related alternative. The FDA drug shortage database is updated weekly and is the most reliable place to check current availability of specific manufacturer lots.

Pharmacists in New Hampshire are permitted to contact a prescribing clinician to request a therapeutic substitution (for example, switching from Adderall XR to Vyvanse or to immediate-release mixed amphetamine salts) when a product is unavailable, but they cannot make that switch without prescriber authorization. Patients who encounter supply problems should call their prescribing clinician, not just the pharmacy, to authorize a substitution quickly.

Clinical Evidence Supporting Adderall XR Prescribing

Amphetamine-based medications have one of the most replicated evidence bases in psychiatry. The landmark MTA Cooperative Group trial (Arch Gen Psychiatry 1999, N=579) compared intensive medication management, behavioral treatment, combined treatment, and community care over 14 months in children aged 7 to 9.9 years with ADHD combined type. Medication management produced statistically significant improvements in ADHD symptom scores compared to behavioral treatment alone (P<0.001 for teacher-rated inattention and hyperactivity-impulsivity). The combined treatment group showed additional benefits in non-ADHD outcomes such as reading achievement and parent-child relations.

For adults, a meta-analysis published in JAMA Psychiatry (Cortese et al., 2018) pooled 133 randomized controlled trials covering 14 medications and found that amphetamines produced the largest effect size for ADHD symptom reduction in adults (standardized mean difference 0.79 to 95% CI 0.63 to 0.95) compared to placebo. That figure reflects a clinically meaningful response rate and explains why amphetamine salts remain first-line pharmacotherapy in most clinical guidelines.

The American Academy of Child and Adolescent Psychiatry (AACAP) Practice Parameter for ADHD states: "Stimulant medications are the most effective pharmacological treatments for ADHD and have the largest evidence base of any psychotropic medication class in child psychiatry." That guideline recommendation has been stable across the 2007 to 2018, and most recent updates.

Safety Considerations New Hampshire Patients Should Know

Mixed amphetamine salts carry FDA black-box labeling noting the high potential for abuse and dependence as Schedule II stimulants. Common adverse effects include decreased appetite, insomnia, elevated heart rate, and increased blood pressure. The prescribing information for Adderall XR warns against use in patients with symptomatic cardiovascular disease, structural cardiac abnormalities, moderate to severe hypertension, hyperthyroidism, or a history of drug abuse.

A cardiovascular safety review published in JAMA (Cooper et al., 2011, N=1,200,438) found no significant increase in the risk of serious cardiovascular events (myocardial infarction, stroke, sudden cardiac death) among current users of ADHD medications versus non-users (adjusted hazard ratio 0.75 to 95% CI 0.52 to 1.03). This study covered adults aged 25 to 64. The finding does not eliminate cardiac risk entirely in higher-risk subgroups, but it provides important context for patients and prescribers weighing benefit versus risk.

Prescribers in New Hampshire must check the New Hampshire Prescription Drug Monitoring Program (PDMP) before issuing any Schedule II prescription. The PDMP is integrated into most electronic health record systems used by New Hampshire clinicians and provides a same-day history of controlled substance fills at any in-state pharmacy.

Practical Steps for New Hampshire Patients Starting or Transferring Adderall XR Care

Patients new to New Hampshire who have an existing Adderall XR prescription from another state cannot simply transfer that prescription to a New Hampshire pharmacy. Schedule II prescriptions are non-transferable under federal law. The patient needs a new written or electronic prescription from either their out-of-state prescriber (if that prescriber holds a current DEA registration valid in NH) or from a new New Hampshire-licensed clinician.

Establishing care with a new prescriber in New Hampshire typically takes two to six weeks for an initial appointment, though telehealth platforms with NH-licensed clinicians may offer first appointments within one to five business days. During the gap, patients should request a 30-day emergency supply where permitted and document their prior treatment records.

A 30-day supply of generic mixed amphetamine salts XR 20 mg dispensed at a Concord, NH pharmacy using a GoodRx coupon as of January 2026 costs approximately $18 to $28.